Pokorná L, Revilla A, Havel J, Patocka J
Masaryk University, Faculty of Science, Department of Analytical Chemistry, Brno, Czech Republic.
Electrophoresis. 1999 Jul;20(10):1993-7. doi: 10.1002/(SICI)1522-2683(19990701)20:10<1993::AID-ELPS1993>3.0.CO;2-5.
Galanthamine is a third-generation cholinesterase inhibitor used against Alzheimer's disease. New analytical methods for the determination of galanthamine in pharmaceutical preparatives and biological fluids, such as urine and serum, were developed. An experimental design and artificial neural network approach were used for method optimization. Thirty-five ppb of galanthamine were determined in serum samples (with addition of 10 mM magnesium chloride and using solid-phase preconcentration).
加兰他敏是一种用于治疗阿尔茨海默病的第三代胆碱酯酶抑制剂。已开发出用于测定药物制剂以及生物流体(如尿液和血清)中加兰他敏的新分析方法。采用实验设计和人工神经网络方法对方法进行优化。在血清样品中测定出35 ppb的加兰他敏(添加10 mM氯化镁并使用固相预富集)。